Predicting stage ypT0-1N0 for nonradical management in patients with middle or low rectal cancer who undergo neoadjuvant chemoradiotherapy: a retrospective cohort study.
Jeehye LeeIn Jun YangJung Wook SuhHong Min AnHeung-Kwon OhDuck-Woo KimYoung Hoon KimKyoung Ho LeeSung-Bum KangPublished in: Annals of surgical treatment and research (2022)
Stage cT1-2 and well differentiation are predictors of ypT0-1N0, while fungating tumors could be considered clinically meaningful, possibly identifying candidates for nonradical treatment post-CCRT.